Skip to main content
Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)
China flag China · Delayed Price · Currency is CNY
10.49
-0.41 (-3.76%)
Nov 13, 2026, 3:00 PM CST

SHA:603439 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
52.8446.25274.03292.7201.28152.28
Depreciation & Amortization
74.0274.0275.7236.916.1911.17
Other Amortization
0.90.90.290.691.660.04
Loss (Gain) From Sale of Assets
0.120.120.17-0.590.090.15
Asset Writedown & Restructuring Costs
122.01122.010.570.050.180.01
Loss (Gain) From Sale of Investments
2.622.62-1.96-55.16-10.96-17.87
Provision & Write-off of Bad Debts
-5.58-5.589.93.3510.30.99
Other Operating Activities
66.9834.4631.5110.89-3.954.79
Change in Accounts Receivable
196.23196.23-295.56-124.07-79.55-83.04
Change in Inventory
92.6892.68-147.99-7.06-9.45-41.13
Change in Accounts Payable
-408.69-408.69167.69119.02161.24127.24
Change in Other Net Operating Assets
13.7313.730.154.146.30.76
Operating Cash Flow
203.69164.58107.07276.7293.29155.04
Operating Cash Flow Growth
198.78%53.71%-61.30%-5.66%89.17%145.13%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-22.89-25.84-45.2-108.73-119.91-26.08
Sale of Property, Plant & Equipment
0.720.640.552.050.180.05
Cash Acquisitions
----543.04-160.04-
Divestitures
-0.09-0.09--0.010.65-
Investment in Securities
4.49-203.8-59.9634.53880.7
Other Investing Activities
-102.630.661.611.451.92-34.08
Investing Cash Flow
-120.4-228.44-103-613.78-266.5620.59

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-----200
Long-Term Debt Issued
-570.54351.22504205-
Total Debt Issued
563.46570.54351.22504205200
Short-Term Debt Repaid
------200
Long-Term Debt Repaid
--422.94-309.7-205.45-200-
Lease Payments
-4.03-4.03-9.85-0.45--
Total Debt Repaid
-649.81-422.94-309.7-205.45-200-200
Net Debt Issued (Repaid)
-86.35147.641.52298.555-
Issuance of Common Stock
--39.23--26.55
Repurchase of Common Stock
-7.73-7.73-100.41-30--
Common Dividends Paid
-43.28-161.44-104.04-50.92-8.92-110.21
Dividends Paid
-43.28-161.44-104.04-50.92-8.92-110.21
Other Financing Activities
-24.44-23.121203.82.2
Financing Cash Flow
-161.79-21.57-100.6337.63-0.12-81.46

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-78.51-85.43-96.530.5526.694.17

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
180.8138.7461.87167.97173.38128.96
Free Cash Flow Growth
384.70%124.23%-63.16%-3.12%34.45%1017.56%
Free Cash Flow Margin
11.05%8.15%2.89%10.27%14.43%13.73%
Free Cash Flow Per Share
0.430.330.150.410.420.31
Levered Free Cash Flow
168.83-57.5297.61-36.78127.6854.78
Unlevered Free Cash Flow
179.91-50.6106.74-34.2130.9659.99
Free Cash Flow After Leases
176.77134.752.02167.52173.38128.96

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
178.59191.18210.8175.31116.04100.28
Change in Working Capital
-110.22-110.22-283.17-12.1378.493.47